Cairo MS - Search Results

1

Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study.

Cairo MS, Davenport V, Bessmertny O, Goldman SC, Berg SL, Kreissman SG, Laver J, Shen V, Secola R, van de Ven C, Reaman GH. Cairo MS, et al. Br J Haematol. 2005 Jan;128(1):49-58. doi: 10.1111/j.1365-2141.2004.05281.x. Br J Haematol. 2005. PMID: 15606549 Free article. Clinical Trial.

2

In vivo hematological effects of seven days of rhIL-6 in neonatal rats.

Cairo MS, Plunkett JM, Clark S, van de Ven C. Cairo MS, et al. Am J Pediatr Hematol Oncol. 1992 Spring;14(1):44-7. doi: 10.1097/00043426-199221000-00006. Am J Pediatr Hematol Oncol. 1992. PMID: 1550262

3

Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.

Cairo MS, Plunkett JM, Mauss D, Van de ven C. Cairo MS, et al. Blood. 1990 Nov 1;76(9):1788-94. Blood. 1990. PMID: 1699622 Free article.

4

Sequential administration of interleukin-6 and granulocyte-colony stimulating factor in newborn rats: modulation of newborn granulopoiesis and thrombopoiesis.

Cairo MS, Plunkett JM, Nguyen A, Clark S, van de Ven C. Cairo MS, et al. Pediatr Res. 1991 Dec;30(6):554-9. doi: 10.1203/00006450-199112000-00013. Pediatr Res. 1991. PMID: 1725208

5

Recombinant human granulocyte-macrophage colony-stimulating factor primes neonatal granulocytes for enhanced oxidative metabolism and chemotaxis.

Cairo MS, van de Ven C, Toy C, Mauss D, Sender L. Cairo MS, et al. Pediatr Res. 1989 Nov;26(5):395-9. doi: 10.1203/00006450-198911000-00001. Pediatr Res. 1989. PMID: 2554242

6

Clinical and laboratory experience in marrow harvesting in children for autologous bone marrow transplantation.

Cairo MS, VandeVen C, Toy C, Sender L. Cairo MS, et al. Bone Marrow Transplant. 1989 May;4(3):305-8. Bone Marrow Transplant. 1989. PMID: 2659115

7

A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.

Gillan ER, Christensen RD, Suen Y, Ellis R, van de Ven C, Cairo MS. Gillan ER, et al. Among authors: cairo ms. Blood. 1994 Sep 1;84(5):1427-33. Blood. 1994. PMID: 7520770 Free article. Clinical Trial.

8

The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.

Cairo MS, Plunkett JM, Schendel P, van de Ven C. Cairo MS, et al. Exp Hematol. 1994 Oct;22(11):1118-23. Exp Hematol. 1994. PMID: 7523164

9

Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.

Cairo MS, Christensen R, Sender LS, Ellis R, Rosenthal J, van de Ven C, Worcester C, Agosti JM. Cairo MS, et al. Blood. 1995 Oct 1;86(7):2509-15. Blood. 1995. PMID: 7670096 Free article. Clinical Trial.

10

Decreased endogenous circulating Steel factor (SLF) levels following allogeneic and autologous BMT: lack of an inverse correlation with post-BMT myeloid engraftment.

Cairo MS, Gillan ER, Weinthal J, Yancik S, van de Ven C, Ho W, Shen V, Buzby JS, Suen Y. Cairo MS, et al. Bone Marrow Transplant. 1993 Feb;11(2):155-61. Bone Marrow Transplant. 1993. PMID: 7679598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

444 results

Search Page

Filters